Literature DB >> 15038406

Hyperbaric oxygenation combined with streptokinase for treatment of arterial thromboembolism of the lower leg.

Slobodan Mihaljević1, Ljiljana Mihaljević, Visnja Majerić-Kogler, Kresimir Oremus.   

Abstract

Thromboembolic occlusion of peripheral arteries is a common problem in patients referred to vascular surgery departments. Standard treatments include catheter aspiration techniques, use of fibrinolytic agents and surgical thrombendarterectomy. Recent reports have described the use of hyperbaric oxygen therapy in patients with limb ischemia, yet their main focus has been on patients with chronic disorders. We present the case of a 74-year-old woman with atrial fibrillation and acute thromboembolic occlusion of the posterior tibial artery. The patient presented with severe pain in the right calf, unresponsive to non-opioid parenteral analgesia and accompanied by coldness, numbness and partial motor palsy of the right foot. After 60 minutes of oxygenation in a hyperbaric chamber with a pressure of 2.2 bar, the pain receded, although without signs of restored blood flow in the occluded artery. After fibrinolytic therapy with streptokinase, patency of the posterior tibial artery was verified by return of palpable pulsations and color Doppler ultrasonography. By combining hyperbaric oxygenation and streptokinase in the treatment of lower-leg arterial thromboembolism we achieved regression of ischemic pain, prolongation of the survival time of tissues compromised by ischemia and resolved the cause of the ischemia. We believe the use of this therapeutic strategy in selected cases of peripheral arterial thromboembolism is justified.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15038406     DOI: 10.1007/BF03040752

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


  8 in total

Review 1.  Non-traumatic vascular emergencies: imaging and intervention in acute arterial conditions.

Authors:  Wojciech Cwikiel; Mehran Midia; David Williams
Journal:  Eur Radiol       Date:  2002-07-09       Impact factor: 5.315

Review 2.  Thrombolysis in the management of lower limb peripheral arterial occlusion--a consensus document. Working Party on Thrombolysis in the Management of Limb Ischemia.

Authors: 
Journal:  Am J Cardiol       Date:  1998-01-15       Impact factor: 2.778

Review 3.  Hyperbaric-oxygen therapy.

Authors:  P M Tibbles; J S Edelsberg
Journal:  N Engl J Med       Date:  1996-06-20       Impact factor: 91.245

4.  Transcutaneous oxygen measurements predict a beneficial response to hyperbaric oxygen therapy in patients with nonhealing wounds and critical limb ischemia.

Authors:  R E Grolman; D K Wilkerson; J Taylor; P Allinson; M A Zatina
Journal:  Am Surg       Date:  2001-11       Impact factor: 0.688

Review 5.  [Increased efficacy of thrombolytic therapy in acute myocardial infarction by improved properties of new thrombolytic agents].

Authors:  K Huber
Journal:  Wien Klin Wochenschr       Date:  2000-09-15       Impact factor: 1.704

6.  Incident thromboembolism in the aorta and the renal, mesenteric, pelvic, and extremity arteries after discharge from the hospital with a diagnosis of atrial fibrillation.

Authors:  L Frost; G Engholm; S Johnsen; H Møller; E W Henneberg; S Husted
Journal:  Arch Intern Med       Date:  2001-01-22

7.  The role of hyperbaric oxygen therapy in ischaemic diabetic lower extremity ulcers: a double-blind randomised-controlled trial.

Authors:  A Abidia; G Laden; G Kuhan; B F Johnson; A R Wilkinson; P M Renwick; E A Masson; P T McCollum
Journal:  Eur J Vasc Endovasc Surg       Date:  2003-06       Impact factor: 7.069

Review 8.  [Hyperbaric oxygenation. An area for the anesthetist?].

Authors:  G Frey; L Lampl; P Radermacher; K H Bock
Journal:  Anaesthesist       Date:  1998-04       Impact factor: 1.041

  8 in total
  1 in total

1.  Hyperbaric oxygen treatment for intrauterine limb ischaemia: a newborn in the chamber.

Authors:  Bengusu Mirasoglu; Hande Cetin; Sevgi Ozdemir Akgun; Samil Aktas
Journal:  Diving Hyperb Med       Date:  2021-06-30       Impact factor: 1.228

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.